|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 22, No 15 (August 1), 2004: pp. 3201-3202 © 2004 American Society of Clinical Oncology. DOI: 10.1200/JCO.2004.99.020
Free Circulating DNA: Good As a Diagnostic Marker in Lung Cancer?
Department of Medical Oncology, Numune Education and Research Hospital, Ankara, Turkey To the Editor: We read with great interest the article by Sozzi et al1 concerning the analysis of circulating DNA in plasma for earlier lung cancer detection. This study showed that higher levels of free circulating DNA can be detected in patients with lung cancer compared with disease-free heavy smokers, by a polymerase chain reaction assay. We want to discuss three important points in this article. One is that circulating DNA that was measured as human telomerase reverse transcriptase (hTERT) gene is not specific to nonsmall-cell lung cancer. Secondly, benign diseases other than malignant disease also cause an increase in circulating DNA levels, and this issue must be discussed. Circulating DNA values must also be compared with stages of lung cancer. Box plots of plasma DNA concentration in nonsmall-cell lung cancer patients and matched controls showed that some of the circulating DNA values in both groups are overlapping, which means that specificity decreases in these cases. Authors' Disclosures of Potential Conflicts of Interest The authors indicated no potential conflicts of interest. REFERENCE
1. Sozzi G, Conte D, Leon M, et al: Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21:3902-3908, 2003 Related Reply
Related Article
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|